RB Global vs Science Applications Intl
Add, change or remove companies; up to four.
KIRA’s take AI analyst
I put RB Global and Science Applications Intl side by side, using each one’s latest annual report. Here is what stands out:
- Science Applications Intl is the larger business, with $7.3B of revenue in fiscal 2026 against $4.6B for RB Global, about 1.6 times as much.
- RB Global grew revenue faster (7.2%, against −2.9%).
- RB Global kept more of each dollar of sales as operating profit (15.5% operating margin, against 7.2%).
- RB Global turned more of its sales into free cash flow (15.7% FCF margin, against 8.0%).
- Science Applications Intl earned a higher return on the capital invested in it (12.8%, against 7.6%).
- Investors pay more for each dollar of RB Global’s earnings: a P/E of 36.3x against 17.0x for Science Applications Intl.
Who comes out ahead
Of the 10 measures where higher (or lower) is clearly better, how many each company leads.
RB Global
RBA
6/10
Revenue growth5-year growthOperating marginNet marginFCF marginNet debt / EBITDA
Science Applications Intl
SAIC
4/10
Return on capitalReturn on equityPiotroski F-scoreShare count change
Side by side
Best in the row
| Latest fiscal year | RBA FY25 | SAIC FY26 |
|---|---|---|
| Size | ||
| Market cap | $15.7B | $6.2B |
| Revenue | $4.6B | $7.3B |
| Free cash flow | $719M | $577M |
| Net income | $428M | $358M |
| Growth | ||
| Revenue growth | 7.2% | −2.9% |
| 5-year growth | 27.2% | 0.6% |
| Share count change | 0.9% | −7.9% |
| Profitability | ||
| Gross margin | — | 12.0% |
| Operating margin | 15.5% | 7.2% |
| Net margin | 9.3% | 4.9% |
| FCF margin | 15.7% | 8.0% |
| Return on capital | 7.6% | 12.8% |
| Return on equity | 7.9% | 23.3% |
| Balance sheet | ||
| Net debt | $2.0B | $2.3B |
| Net debt / EBITDA | 1.7x | 4.2x |
| Dividends and buybacks | $258M | $515M |
| Valuation & quality | ||
| P/E | 36.3x | 17.0x |
| Piotroski F-score | 6 | 7 |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.